Covered recipient · General Payments record
JENNIFER LEE GALAWAY
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2019–2024
$1,657.49
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $523.46 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $150.51 | 7 |
| ConvaTec Inc. | $146.21 | 2 |
| Kerecis Limited | $87.88 | 1 |
| DePuy Synthes Sales Inc. | $39.08 | 1 |
| Amgen Inc. | $35.08 | 2 |
| ORGANOGENESIS INC. | $26.81 | 1 |
| Abbott Laboratories | $23.48 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.48 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125089076 | CMS |
| Amgen Inc. | $17.12 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111579403 | CMS |
| Amgen Inc. | $17.96 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111579405 | CMS |
| Averitas Pharma Inc. | $5.35 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426624 | CMS |
| Averitas Pharma Inc. | $23.57 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426628 | CMS |
| Averitas Pharma Inc. | $20.77 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426632 | CMS |
| Averitas Pharma Inc. | $24.67 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426636 | CMS |
| Averitas Pharma Inc. | $27.33 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426640 | CMS |
| Averitas Pharma Inc. | $28.85 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426644 | CMS |
| Averitas Pharma Inc. | $19.97 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426648 | CMS |
| Boston Scientific Corporation | $14.41 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092356697 | CMS |
| ConvaTec Inc. | $31.88 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151374074 | CMS |
| ConvaTec Inc. | $114.33 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151374076 | CMS |
| DePuy Synthes Sales Inc. | $39.08 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077867883 | CMS |
| Kerecis Limited | $87.88 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120115637 | CMS |
| Organogenesis Inc. | $26.81 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145428322 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.